About: Ritu Saxena
Posts by Ritu Saxena:
-
June 24, 2013 In focus: Circulating Tumor Cells
-
May 27, 2013 Personalized medicine-based diagnostic test for NSCLC
-
April 10, 2013 Hypervascular Hepatocellular Carcinoma: Important clues from Gadoxetic acid-based MRI imaging
-
March 27, 2013 In Focus: Targeting of Cancer Stem Cells
-
March 22, 2013 In Focus: Identity of Cancer Stem Cells
-
March 8, 2013 In focus: Melanoma therapeutics
-
March 4, 2013 Genomics-based cure for diabetes on-the-way
-
February 18, 2013 In focus: Melanoma Genetics
-
January 29, 2013 In focus: Triple Negative Breast Cancer
-
January 15, 2013 Exploring the role of vitamin C in Cancer therapy
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta